大动脉炎相关肺动脉高压的临床特征与生存:全国性研究
基于中国国家罕见病登记系统,纳入140例大动脉炎相关肺动脉高压(TA-PH)患者,诊断时平均年龄41.4岁,女性占81%,血流动力学和功能受损严重。1年、3年、5年总生存率分别为94.0%、83.2%、77.2%。晕厥、NT-proBNP水平和平均右房压与全因死亡风险增加相关。
要点
- TA-PH患者以女性为主,诊断时血流动力学和功能受损严重。
- 1年、3年、5年生存率分别为94.0%、83.2%、77.2%。
- 晕厥、NT-proBNP升高和平均右房压升高是全因死亡预测因素。
核心结论
- TA-PH患者主要为女性且血流动力学严重受损,超过80%的患者至少存活3年。
- 晕厥、NT-proBNP水平和平均右房压与全因死亡风险增加独立相关。
研究设计与样本
- 基于中国国家罕见病登记系统的全国代表性队列研究,纳入2007年1月至2019年1月共140例符合诊断标准的TA-PH患者。
主要发现
- 诊断时平均年龄41.4岁,女性占81%,患者存在严重血流动力学和功能损伤。
- 接受肺动脉高压靶向药物治疗的患者NT-proBNP和血流动力学指标有显著改善。
- 总体1年、3年、5年生存率分别为94.0%、83.2%、77.2%。
- 晕厥的校正HR为5.38(95%CI 1.77-16.34,P=0.003),NT-proBNP的校正HR为1.04(95%CI 1.03-1.06,P<0.001),平均右房压的校正HR为1.07(95%CI 1.01-1.13,P=0.015)。
临床怎么用
- 应关注TA-PH患者的晕厥病史、NT-proBNP水平和平均右房压以评估死亡风险。
- 药物治疗基于研究者个人意见,无法从现有数据得出明确的风险获益比。
局限性
- 药物治疗基于研究者个人意见,无法从数据中得出明确的风险获益比。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study aimed to assess the clinical characteristics and long-term survival outcome in patients with Takayasu's arteritis-associated pulmonary hypertension (TA-PH). METHODS AND RESULTS: We conducted a nationally representative cohort study of TA-PH using data from the National Rare Diseases Registry System of China. Patients with pulmonary artery involvement who fulfilled the diagnostic criteria of Takayasu's arteritis and pulmonary hypertension were included. The primary outcome was the time from diagnosis of TA-PH to the occurrence of all-cause death. Between January 2007 and January 2019, a total of 140 patients were included, with a mean age of 41.4 years at diagnosis, and a female predominance (81%). Patients with TA-PH had severely haemodynamic and functional impairments at diagnosis. Significant improvements have been found in N-terminal pro-B-type natriuretic peptide (NT-proBNP) and haemodynamic profiles in patients with TA-PH receiving drugs approved for pulmonary arterial hypertension. The overall 1-, 3-, and 5-year survival rates in TA-PH were 94.0%, 83.2%, and 77.2%, respectively. Predictors associated with an increased risk of all-cause death were syncope [adjusted hazard ratio (HR) 5.38 (95% confidence interval 1.77-16.34), P = 0.003], NT-proBNP level [adjusted HR 1.04 (1.03-1.06), P < 0.001], and mean right atrial pressure [adjusted HR 1.07 (1.01-1.13), P = 0.015]. CONCLUSION: Patients with TA-PH were predominantly female and had severely compromised haemodynamics. More than 80% of patients in our cohort survived for at least 3 years. Medical treatment was based on investigators' personal opinions, and no clear risk-to-benefit ratio can be derived from the presented data.
引用
- Jiang X, Zhu YJ, Zhou YP, et al. Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study. Eur Heart J. 2021. PMID: 34506618. doi:10.1093/eurheartj/ehab599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。